Vertex Pharmaceuticals has given Mirum Pharmaceuticals the blueprint for success in rare diseases.

A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...

Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...

Obituaries for Perry County for the weeks preceding April 18. Betty Trout died on Sunday, April 5, 2026, at her home in ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

Underwriters were given a 30-day option to purchase up to 1.74 million additional shares. ・Trevi is currently developing Haduvio, its treatment for chronic cough in patients with idiopathic pulmonary ...

Upright area-detector CT is equal to or better than supine ADCT in detecting the loss in lung function and assessing the severity of PPF.

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

Morgan Stanley, Leerink Partners, Cantor, and Stifel are acting as joint book-running managers for the offering and Oppenheimer & Co. is acting as lead manager. The offering is subject to market and ...

Vertex Pharmaceuticals' business will suffer if other drugmakers launch competing cystic fibrosis drugs. Despite this threat, ...

Columnist Kylene Henderson's husband, Donnie, had to pivot in many aspects of life due to PF, including changing his career.